Is RUBY or DIVO a better dividend investment in 2026?

RUBY currently yields 3508.77% with a 5% 5-year dividend growth rate. DIVO yields 6.62% with 5% growth. The better choice depends on your goal: RUBY offers higher current income.

What is the dividend yield difference between RUBY and DIVO?

RUBY has a forward dividend yield of 3508.77% ($2.00/share annually). DIVO yields 6.62% ($2.91/share annually). The yield gap is 3502.15 percentage points.

Home › Compare › RUBY vs DIVO

RUBY vs DIVO: Dividend Comparison 2026

RUBY yields 3508.77% · DIVO yields 6.62%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RUBY wins by $2034141393542.05M in total portfolio value

INVESTMENT

TIME HORIZON10 years

RUBY

● Live price

3508.77%

Share price

$0.06

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2034141393542.08M

Annual income

$1,926,153,862,282,748,700.00

Full RUBY calculator →

DIVO

● Live price

6.62%

Share price

$44.00

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.0K

Annual income

$1,008.47

Full DIVO calculator →

Portfolio growth — RUBY vs DIVO

📍 RUBY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RUBY	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RUBY + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RUBY pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RUBY

Annual income on $10K today (after 15% tax)

$298,245.61/yr

After 10yr DRIP, annual income (after tax)

$1,637,230,782,940,336,400.00/yr

DIVO

Annual income on $10K today (after 15% tax)

$562.67/yr

After 10yr DRIP, annual income (after tax)

$857.20/yr

At 15% tax rate, RUBY beats the other by $1,637,230,782,940,335,600.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RUBY + DIVO for your $10,000?

RUBY: 50%DIVO: 50%

100% DIVO50/50100% RUBY

Portfolio after 10yr

$1017070696771.06M

Annual income

$963,076,931,141,374,800.00/yr

Blended yield

94.69%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on RUBY right now

RUBY

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Altman Z

-81.9

Piotroski

2/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RUBY buys

DIVO buys

No recent congressional trades found for RUBY or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRUBYDIVO

Forward yield	3508.77% ✓	6.62%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$2034141393542.08M ✓	$31.0K
Annual income after 10y	$1,926,153,862,282,748,700.00 ✓	$1,008.47
Total dividends collected	$2026733119198.63M ✓	$8.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: RUBY vs DIVO ($10,000, DRIP)

Year	RUBY Portfolio	RUBY Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$361,577	$350,877.19	$11,362	$661.96	+$350.2K → RUBY
2	$12,243,821	$11,856,933.69	$12,860	$702.91	+$12.23M → RUBY
3	$388,336,948	$375,236,059.53	$14,504	$743.56	+$388.32M → RUBY
4	$11,538,279,357	$11,122,758,822.00	$16,303	$783.73	+$11538.26M → RUBY
5	$321,205,540,543	$308,859,581,631.20	$18,268	$823.31	+$321205.52M → RUBY
6	$8,379,307,864,544	$8,035,617,936,162.96	$20,408	$862.17	+$8379307.84M → RUBY
7	$204,877,671,222,196	$195,911,811,807,134.25	$22,737	$900.20	+$204877671.20M → RUBY
8	$4,695,974,086,156,479	$4,476,754,977,948,728.50	$25,266	$937.31	+$4695974086.13M → RUBY
9	$100,922,926,410,592,910	$95,898,234,138,405,470.00	$28,008	$973.42	+$100922926410.56M → RUBY
10	$2,034,141,393,542,082,800	$1,926,153,862,282,748,700.00	$30,977	$1,008.47	+$2034141393542.05M → RUBY

RUBY vs DIVO: Complete Analysis 2026

RUBY — Stock

Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

Full RUBY Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this RUBY vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RUBY vs SCHD RUBY vs JEPI RUBY vs O RUBY vs KO RUBY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.